Related Experiment Videos
Aspects of lung cancer gene expression profiling
Gerit Müller-Hagen1, Thomas Beinert, Anette Sommer
1Charité - Universitary Medicine Berlin, Campus Virchow, Department of Internal Medicine/Infectious Diseases, Humboldt-University, Augustenburger Platz 1, 13353 Berlin, Germany. gerit.mueller-hagen@charite.de
Current Opinion in Drug Discovery & Development
|June 26, 2004
Summary
Gene expression profiling offers new ways to diagnose and treat lung cancer. This review covers RNA-level analyses to find novel therapeutic targets for this common disease.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Lung cancer is a leading global cause of death.
- Late-stage diagnosis is common, limiting treatment success.
- Current diagnostic and therapeutic strategies require improvement.
Purpose of the Study:
- To review gene expression profiling in lung cancer.
- To identify novel diagnostic and prognostic markers.
- To explore targeted therapy development based on molecular findings.
Main Methods:
- Summarizes RNA-level analyses of lung cancer.
- Includes suppression subtractive hybridization (SSH).
- Covers serial analysis of gene expression (SAGE) and microarrays (cDNA and oligonucleotide).
Main Results:
- Gene expression profiling reveals potential diagnostic and prognostic markers.
- Identifies molecular targets for small-molecule and antibody-based therapies.
- Highlights the importance of molecular-level understanding for treatment innovation.
Conclusions:
- Gene expression profiling is crucial for advancing lung cancer research.
- Translating molecular findings into targeted therapies is a key goal.
- Further research is needed to improve lung cancer diagnosis and treatment outcomes.